Compounds > tetradecanoylphorbol acetate
Page last updated: 2024-08-23

tetradecanoylphorbol acetate and Conjunctivitis, Allergic

tetradecanoylphorbol acetate has been researched along with Conjunctivitis, Allergic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ambach, A; Bonnekoh, B; Gollnick, H1

Other Studies

1 other study(ies) available for tetradecanoylphorbol acetate and Conjunctivitis, Allergic

ArticleYear
Perforin hyperreleasability and depletion in cytotoxic T cells from patients with exacerbated atopic dermatitis and asymptomatic rhinoconjunctivitis allergica.
    The Journal of allergy and clinical immunology, 2001, Volume: 107, Issue:5

    Topics: Antibodies, Monoclonal; Antigens, Differentiation, T-Lymphocyte; Antigens, Neoplasm; CD4-CD8 Ratio; Conjunctivitis, Allergic; Cytoplasmic Granules; Cytotoxicity, Immunologic; Dermatitis, Atopic; Flow Cytometry; Humans; Hypersensitivity, Immediate; Immunoglobulin E; Ionomycin; Killer Cells, Natural; Membrane Glycoproteins; Perforin; Pore Forming Cytotoxic Proteins; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; T-Lymphocytes, Cytotoxic; Tetradecanoylphorbol Acetate; Th1 Cells; Th2 Cells; Time Factors

2001